Several studies have shown that serum adiponectin levels are inversely correlated with the incidence and severity of metabolic dysfunction and cardiovascular diseases, such as obesity, diabetes mellitus, coronary heart disease, and hypertension [19–22]. This evidence concerns the gene ADIPOQ and cardiovascular disorder.